Established in 1993, XTL became a public company in 2000. XTL’s ADRs (1:20 ratio) are publicly traded on the NASDAQ and its shares are traded on the Tel Aviv Stock Exchange (NASDAQ: XTLB, TASE: XTLB).

Clicking on the below links will cause you to leave the Company’s website and XTL Biopharmaceuticals Ltd. makes no claims concerning the accuracy of the information provided on the pages associated with the above link and will not be held liable for any use of such information.